$GILD GILEAD SCIENCES INC Insider Trading Week 27/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC in week 27/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 0 | |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 0 | |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.97 | 8,630 | 733,301 | 1,058,963 | 1.1 M to 1.1 M (-0.81 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.97 | 8,630 | 733,301 | 1,058,963 | 1.1 M to 1.1 M (-0.81 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.28 | 103,370 | 8,711,620 | 1,067,593 | 1.2 M to 1.1 M (-8.83 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.28 | 103,370 | 8,711,620 | 1,067,593 | 1.2 M to 1.1 M (-8.83 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 795 | 0 | 25,492 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 16.40 | 100,000 | 1,639,500 | 500,000 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 85.03 | 30,718 | 2,612,093 | 4,019,727 | 4.1 M to 4 M (-0.76 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 84.68 | 64,582 | 5,468,629 | 4,050,445 | 4.1 M to 4.1 M (-1.57 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.36 | 4,700 | 391,801 | 4,115,027 | 4.1 M to 4.1 M (-0.11 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 16.40 | 100,000 | 1,639,500 | 4,119,727 | 4 M to 4.1 M (+2.49 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 24.91 | 2,000 | 49,810 | 26,226 | |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 83.12 | 2,000 | 166,250 | 61,122 | 63.1 K to 61.1 K (-3.17 %) |
| Jul 06 2016 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 24.91 | 2,000 | 49,810 | 63,122 | 61.1 K to 63.1 K (+3.27 %) |